Science & Technology
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44CA281538-01A1
Award Ceiling
$2.0M
Award Floor
$2.0M
Close Date
Nov 30, 2025
Total Funding
$2.0M
Expected Awards
1
Posted Date
Sep 19, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R44CA281538-01A1
Description
SBIR Phase Phase II award: "Aerosolized Epigenetic Therapy for Metastatic Lung Cancer" awarded to Nob Hill Therapeutics, Inc. in Albuquerque, New Mexico. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,000,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.